The application of genome editing in studying hearing loss
Bing Zou(University of Miami), Xuezhong Liu(University of Miami), Rahul Mittal(University of Miami), Weijia Kong(Wuhan Union Hospital), Yilai Shu(Fudan University), Youg Feng(Central South University), Shiming Yang(Ministry of Education of the People's Republic of China), Dinghua Xie(Central South University), Zheng‐Yi Chen(Massachusetts Eye and Ear Infirmary), Zhongmin Lu(University of Miami), M’hamed Grati(University of Miami), Yong Tao(Shanghai Ninth People's Hospital)
Cited by 57
Related Papers
Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo
|Nature Biotechnology|2014|1.5k
Neurotransmitters: The Critical Modulators Regulating Gut–Brain Axis
|Journal of Cellular Physiology|2016|626
Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents
|Nature|2017|547
AAV1-hOTOF gene therapy for autosomal recessive deafness 9: a single-arm trial
|The Lancet|2024|323